CS
Group leader

Pavel Majer

Pavel Majer
Contacts
mail pavel.majerinvalid-email-name@invalid-email-domainuochb.cas.cz
phone +420 220 183 125
Group
Drug Discovery
Pavel Majer Group
All publications

Recent papers

Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors
V. Zima K. Radilová M. Kožíšek C. B. Albinana E. Karlukova J. Brynda J. Fanfrlík
M. Flieger
J. Hodek J. Weber P. Majer J. Konvalinka A. Machara
European Journal of Medicinal Chemistry 208: Early View (2020)
Go to the publication arrow
Mapping of CaM, S100A1 and PIP2-Binding Epitopes in the Intracellular N- and C-Termini of TRPM4
K. Boušová
I. Barvík
P. Heřman
P. Herman
K. Hofbauerová
K. Hofbauerová
L. Monincová P. Majer M. Zouharová V. Vetýšková K. Poštulková J. Vondrášek
International Journal of Molecular Sciences 21 (12): 4323 (2020)
Go to the publication arrow
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
M. H. Oh
I. H. Sun
L. Zhao
R. D. Leone
I. M. Sun
W. Xu
S. L. Collins
A. J. Tam
R. L. Blosser
C. H. Patel
J. M. Englert
M. L. Arwood
J. Wen
Y. Chan-Li
L. Tenora P. Majer
R. Rais
B. S. Slusher
M. R. Horton
J. D. Powell
Journal of Clinical Investigation 130 (7): 3865-3884 (2020)
Go to the publication arrow
Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)
J. Tykvart V. Navrátil M. Kugler P. Šácha J. Schimer A. Hlavačková L. Tenora J. Zemanová M. Dejmek
V. Král
M. Potáček
P. Majer U. Jahn J. Brynda P. Řezáčová J. Konvalinka
SLAS Discovery 25 (9): 1026-1037 (2020)
Go to the publication arrow